Non-small cell lung carcinoma (NSCLC), single core per case. Pathology grade, TNM Classification, and Clinical stage information available. Replacing LC121c.
-55 cases of squamous cell carcinoma
- 55 cases of adenocarcinoma
- 6 cases of normal adjacent tissue
- 4 cases of normal lung tissue
Price
$345.00
Catalogue No | LC121d |
Species | Human |
Fixative | Formalin |
Total Cases | 120 |
Total Cores | 120 |
Core Diameter | 1 mm |
Section Thickness | 5 µm |
Storage | Short term RT; Long term 4ºC |
Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
A | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
B | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
C | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
D | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
E | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
F | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
G | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
H | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
I | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
J | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU | LU |
N | N/ |
Showing All Data
No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type |
---|---|---|---|---|---|---|---|---|---|
1 | A1 | 63 | F | Lung | Squamous cell carcinoma with necrosis | 3 | T3N1M0 | IIIA | Malignant |
2 | A2 | 68 | M | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant |
3 | A3 | 66 | M | Lung | Squamous cell carcinoma | 2 | T2N2M0 | IIIA | Malignant |
4 | A4 | 66 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T3N1M0 | IIIA | Malignant |
5 | A5 | 63 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
6 | A6 | 48 | M | Lung | Squamous cell carcinoma | 1 | T2N1M0 | IIA | Malignant |
7 | A7 | 57 | M | Lung | Squamous cell carcinoma | 1 | T3N1M0 | IIIA | Malignant |
8 | A8 | 64 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
9 | A9 | 68 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
10 | A10 | 65 | M | Lung | Squamous cell carcinoma (sparse) | 2 | T2N0M0 | IB | Malignant |
11 | A11 | 54 | M | Lung | Squamous cell carcinoma | 3 | T1N0M0 | IA | Malignant |
12 | A12 | 54 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
13 | B1 | 64 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
14 | B2 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
15 | B3 | 68 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
16 | B4 | 54 | M | Lung | Squamous cell carcinoma (sparse) | 2 | T2N1M0 | IIA | Malignant |
17 | B5 | 64 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
18 | B6 | 68 | M | Lung | Squamous cell carcinoma with necrosis | 2 | T2N0M0 | IB | Malignant |
19 | B7 | 65 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
20 | B8 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
21 | B9 | 59 | M | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant |
22 | B10 | 55 | M | Lung | Squamous cell carcinoma | 2 | T2N1M0 | IIA | Malignant |
23 | B11 | 59 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant |
24 | B12 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
25 | C1 | 68 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant |
26 | C2 | 68 | M | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant |
27 | C3 | 56 | M | Lung | Squamous cell carcinoma | 2 | T3N2M0 | IIIA | Malignant |
28 | C4 | 64 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
29 | C5 | 60 | M | Lung | Squamous cell carcinoma | 2 | T3N1M0 | IIIA | Malignant |
30 | C6 | 55 | F | Lung | Squamous cell carcinoma | 2 | T2aN0M0 | IB | Malignant |
31 | C7 | 59 | F | Lung | Squamous cell carcinoma (sparse) | 3 | T2N0M0 | IB | Malignant |
32 | C8 | 64 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
33 | C9 | 50 | F | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
34 | C10 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
35 | C11 | 48 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
36 | C12 | 65 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
37 | D1 | 54 | M | Lung | Squamous cell carcinoma | 3 | T2N1M0 | IIA | Malignant |
38 | D2 | 58 | M | Lung | Squamous cell carcinoma | 2 | T2N0M0 | IB | Malignant |
39 | D3 | 68 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
40 | D4 | 77 | M | Lung | Squamous cell carcinoma | 3 | T4N1M0 | IIIA | Malignant |
41 | D5 | 56 | F | Lung | Squamous cell carcinoma | 3 | T4N0M0 | IIIA | Malignant |
42 | D6 | 62 | M | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant |
43 | D7 | 64 | M | Lung | Squamous cell carcinoma | 3 | T2N0M0 | IB | Malignant |
44 | D8 | 65 | M | Lung | Squamous cell carcinoma | 3 | T3N0M0 | IIB | Malignant |
45 | D9 | 70 | M | Lung | Squamous cell carcinoma | 3 | T4N2M0 | IIIB | Malignant |
46 | D10 | 66 | M | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant |
47 | D11 | 71 | M | Lung | Squamous cell carcinoma | 2 | T2N2M0 | IIIA | Malignant |
48 | D12 | 60 | M | Lung | Squamous cell carcinoma | 3 | T4N0M0 | IIIA | Malignant |
49 | E1 | 65 | M | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant |
50 | E2 | 60 | F | Lung | Squamous cell carcinoma | 3 | T2N2M0 | IIIA | Malignant |
51 | E3 | 42 | M | Lung | Squamous cell carcinoma | 3 | T3N1M0 | IIIA | Malignant |
52 | E4 | 64 | M | Lung | Squamous cell carcinoma | 3 | T3N2M0 | IIIA | Malignant |
53 | E5 | 70 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant |
54 | E6 | 64 | M | Lung | Squamous cell carcinoma | 3 | T2bN3M0 | IIIB | Malignant |
55 | E7 | 64 | M | Lung | Squamous cell carcinoma | 3 | T2aN0M0 | IB | Malignant |
56 | E8 | 65 | M | Lung | Adenocarcinoma | 2 | T3N2M0 | IIIA | Malignant |
57 | E9 | 49 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
58 | E10 | 62 | F | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
59 | E11 | 62 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
60 | E12 | 39 | F | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
61 | F1 | 47 | F | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
62 | F2 | 53 | F | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
63 | F3 | 54 | F | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
64 | F4 | 51 | M | Lung | Adenocarcinoma | 2 | T2N0M0 | IB | Malignant |
65 | F5 | 50 | M | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
66 | F6 | 42 | F | Lung | Adenocarcinoma | 2 | T4N1M0 | IIIA | Malignant |
67 | F7 | 59 | M | Lung | Adenocarcinoma | 2 | T4N3M0 | IIIB | Malignant |
68 | F8 | 49 | F | Lung | Adenocarcinoma | 1 | T2N0M0 | IB | Malignant |
69 | F9 | 60 | F | Lung | Adenocarcinoma | 2 | T4N0M0 | IIIA | Malignant |
70 | F10 | 59 | M | Lung | Adenocarcinoma | 2 | T2aN0M0 | IB | Malignant |
71 | F11 | 62 | M | Lung | Adenocarcinoma | 2 | T3N0M0 | IIB | Malignant |
72 | F12 | 68 | F | Lung | Solid adenocarcinoma | - | T2N2M0 | IIIA | Malignant |
73 | G1 | 43 | F | Lung | Solid adenocarcinoma | - | T2N0M0 | IB | Malignant |
74 | G2 | 47 | F | Lung | Solid adenocarcinoma | - | T2N0M0 | IB | Malignant |
75 | G3 | 54 | F | Lung | Solid adenocarcinoma with necrosis | - | T3N0M0 | IIB | Malignant |
76 | G4 | 38 | M | Lung | Adenocarcinoma with necrosis | 3 | T3N0M0 | IIB | Malignant |
77 | G5 | 82 | M | Lung | Adenocarcinoma | 3 | T4N1M0 | IIIA | Malignant |
78 | G6 | 42 | M | Lung | Adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
79 | G7 | 36 | F | Lung | Solid adenocarcinoma | - | T2N2M0 | IIIA | Malignant |
80 | G8 | 54 | M | Lung | Adenocarcinoma | 3 | T2N0M0 | IB | Malignant |
81 | G9 | 39 | M | Lung | Adenocarcinoma | 2 | T4N0M0 | IIIA | Malignant |
82 | G10 | 66 | M | Lung | Solid adenocarcinoma | - | T2N2M0 | IIIA | Malignant |
83 | G11 | 48 | M | Lung | Papillary adenocarcinoma | 2 | T3N1M0 | IIIA | Malignant |
84 | G12 | 60 | M | Lung | Adenocarcinoma | 3 | T2N2M0 | IIIA | Malignant |
85 | H1 | 30 | F | Lung | Adenocarcinoma with necrosis (sparse) | - | T4N1M1 | IV | Malignant |
86 | H2 | 56 | M | Lung | Adenocarcinoma | 3 | T2aN2M0 | IIIA | Malignant |
87 | H3 | 55 | F | Lung | Adenocarcinoma | 3 | T2aN0M0 | IB | Malignant |
88 | H4 | 54 | F | Lung | Solid adenocarcinoma | - | T3N1M0 | IIIA | Malignant |
89 | H5 | 72 | M | Lung | Solid adenocarcinoma | - | T2N2M0 | IIIA | Malignant |
90 | H6 | 56 | M | Lung | Solid adenocarcinoma | - | T3N1M0 | IIIA | Malignant |
91 | H7 | 47 | F | Lung | Solid adenocarcinoma | - | T2N0M0 | IB | Malignant |
92 | H8 | 69 | M | Lung | Adenocarcinoma | * | T2N0M0 | IB | Malignant |
93 | H9 | 65 | M | Lung | Solid adenocarcinoma with necrosis | - | T3N0M0 | IIB | Malignant |
94 | H10 | 48 | M | Lung | Solid adenocarcinoma | - | T2aN0M0 | IB | Malignant |
95 | H11 | 60 | F | Lung | Solid adenocarcinoma | - | T3N0M0 | IIB | Malignant |
96 | H12 | 22 | F | Lung | Solid adenocarcinoma | - | T3N0M0 | IIB | Malignant |
97 | I1 | 65 | F | Lung | Solid adenocarcinoma | - | T3N1M0 | IIIA | Malignant |
98 | I2 | 62 | M | Lung | Solid adenocarcinoma | - | T3N1M0 | IIIA | Malignant |
99 | I3 | 35 | M | Lung | Solid adenocarcinoma | - | T3N2M0 | IIIA | Malignant |
100 | I4 | 61 | M | Lung | Solid adenocarcinoma | - | T2N2M0 | IIIA | Malignant |
101 | I5 | 51 | M | Lung | Solid adenocarcinoma | - | T3N0M0 | IIB | Malignant |
102 | I6 | 73 | M | Lung | Solid adenocarcinoma | - | T3N1M0 | IIIA | Malignant |
103 | I7 | 60 | M | Lung | Solid adenocarcinoma | - | T2N0M0 | IB | Malignant |
104 | I8 | 62 | F | Lung | Solid adenocarcinoma | - | T4N0M0 | IIIA | Malignant |
105 | I9 | 54 | F | Lung | Solid adenocarcinoma | - | T4N1M0 | IIIA | Malignant |
106 | I10 | 50 | F | Lung | Solid adenocarcinoma | - | T3N0M0 | IIB | Malignant |
107 | I11 | 49 | F | Lung | Solid adenocarcinoma | - | T2N0M0 | IB | Malignant |
108 | I12 | 50 | M | Lung | Solid adenocarcinoma | * | T2N1M0 | IIA | Malignant |
109 | J1 | 62 | M | Lung | Solid adenocarcinoma | - | T2aN0M0 | IB | Malignant |
110 | J2 | 44 | M | Lung | Solid adenocarcinoma | - | T1N0M0 | IA | Malignant |
111 | J3 | 56 | M | Lung | Normal Adjacent Tissue | - | - | - | NAT |
112 | J4 | 57 | M | Lung | Normal Adjacent Tissue | - | - | - | NAT |
113 | J5 | 51 | F | Lung | Normal Adjacent Tissue | - | - | - | NAT |
114 | J6 | 68 | M | Lung | Normal Adjacent Tissue | - | - | - | NAT |
115 | J7 | 53 | F | Lung | Normal Adjacent Tissue | - | - | - | NAT |
116 | J8 | 45 | M | Lung | Normal Adjacent Tissue | - | - | - | NAT |
117 | J9 | 27 | M | Lung | Lung tissue | - | - | - | Normal |
118 | J10 | 47 | M | Lung | Lung tissue | - | - | - | Normal |
119 | J11 | 16 | F | Lung | Lung tissue | - | - | - | Normal |
120 | J12 | 46 | M | Lung | Lung tissue | - | - | - | Normal |
N/A | N/A | N/A | N/A | N/A | _pheochromocytoma_ Tissue Marker | N/A | N/A | N/A | N/A |